Pharmacometabolomics identifies candidate predictor metabolites of an L‐carnitine treatment mortality benefit in septic shock
Abstract Sepsis‐induced metabolic dysfunction contributes to organ failure and death. L‐carnitine has shown promise for septic shock, but a recent phase II study of patients with vasopressor‐dependent septic shock demonstrated a non‐significant reduction in mortality. We undertook a pharmacometabolo...
Saved in:
Main Authors: | Michael A. Puskarich (Author), Theodore S. Jennaro (Author), Christopher E. Gillies (Author), Charles R. Evans (Author), Alla Karnovsky (Author), Cora E. McHugh (Author), Thomas L. Flott (Author), Alan E. Jones (Author), Kathleen A. Stringer (Author), for the RACE Investigators (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Septic shock
by: V. O. Bitsadze, et al.
Published: (2020) -
Racial disparities in septic shock mortality: a retrospective cohort studyResearch in context
by: Lauren P. Black, et al.
Published: (2024) -
Vasopressin and septic shock
by: Sarah Mousavi
Published: (2015) -
Vasopressors in Septic Shock
by: Vinay H Joshi, et al.
Published: (2018) -
Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
by: Deninson Alejandro Vargas, et al.
Published: (2019)